KalVista Pharmaceuticals, Inc. - COM (KALV)

Historical Portfolio Holders from Q4 2016 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
48.2M
Holdings value Q2 2024
$568M
Value change Q2 2024
+$14.3M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
118
Number of buys Q2 2024
19
Number of sells Q2 2024
-15
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 2.91M $33.7M -$4.08M $11.58 29
2024 Q2 48.2M $568M +$14.3M $11.78 118
2024 Q1 47M $557M +$118M $11.86 128
2023 Q4 37M $453M +$5.79M $12.25 95
2023 Q3 36.3M $349M +$17.9M $9.63 102
2023 Q2 34.5M $310M +$8.86M $9.00 93
2023 Q1 33.7M $265M -$7.24M $7.86 87
2022 Q4 33.8M $229M +$23.5M $6.76 88
2022 Q3 25.6M $372M +$16.6M $14.51 91
2022 Q2 24.3M $239M -$18.2M $9.84 85
2022 Q1 24M $353M -$11.7M $14.74 84
2021 Q4 23.8M $315M -$24.2M $13.23 93
2021 Q3 23.4M $408M -$21.5M $17.45 103
2021 Q2 24.3M $583M +$12.1M $23.96 109
2021 Q1 23.5M $604M +$241M $25.69 115
2020 Q4 14.7M $278M +$4.36M $18.99 80
2020 Q3 16.2M $204M +$2.82M $12.59 61
2020 Q2 16M $194M +$9.42M $12.10 72
2020 Q1 15.7M $120M +$17.2M $7.65 68
2019 Q4 13.7M $244M +$13.4M $17.81 73
2019 Q3 13.2M $153M -$34M $11.60 75
2019 Q2 14.8M $328M +$6.28M $22.15 74
2019 Q1 13.9M $398M +$23.9M $28.62 67
2018 Q4 13M $256M +$7.7M $19.75 56
2018 Q3 12.3M $272M +$113M $22.11 46
2018 Q2 6.32M $51.3M -$1.6M $8.12 24
2018 Q1 6.5M $61.6M +$134K $9.48 23
2017 Q4 6.48M $63.2M -$3M $9.75 23
2017 Q3 7.72M $52.2M +$2.31M $6.73 16
2017 Q2 7.37M $54.1M -$1.77M $7.36 16
2017 Q1 7.59M $59.2M +$2.02M $7.81 17
2016 Q4 7.33M $51.5M +$47M $7.07 18